Evidence map›Paper›PMID 40342982›Full record

ArticleFrontiers in cardiovascular medicine2025

Lipid-lowering therapy (LLT) in 1,100 cardiac rehabilitation patients with coronary heart disease: the LLT-R(ehabilitation) registry.

Frank Noack, Kristina Eckrich, Heinz Völler, Bernhard Schwaab, Viktoria Heinze, Christa Bongarth, Manju Guha, Michael Richter, Nadja Schwark, Alexandra Strobel and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Frank NoackDepartment of Emergency Medicine, University Clinic Halle-Saale, Halle, Germany.
Kristina EckrichDepartment of Cardiology, Clinic Tharandter Wald-Hetzdorf, Halsbrücke, Germany.
Heinz VöllerDepartment of Cardiology, Klinik am See, Rüdersdorf, Germany.
Bernhard SchwaabCurschmann-Clinic Timmendorfer Strand and Medical Faculty, University of Lübeck, Lübeck, Germany.
Viktoria HeinzeDepartment of Cardiology, Paracelsus-Harz-Klinik Bad Suderode, Quedlinburg, Germany.
Christa BongarthDepartment of Cardiology, Clinic Höhenried, Bernried, Germany.
Manju GuhaDepartment of Cardiology, Rehabilitation Clinic Sendesaal, Bremen, Germany.
Michael RichterCoordination Center for Clinical Studies, Martin Luther-University Halle Wittenberg, Halle, Germany.
Nadja SchwarkDepartment of Emergency Medicine, University Clinic Halle-Saale, Halle, Germany.
Alexandra StrobelInstitute of Medical Epidemiology, Biostatistics, and Informatics, Martin Luther-University Halle, Halle, Germany.
Axel SchlittMedical Faculty, Martin Luther-University Halle Wittenberg, Halle, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac rehabilitation (CR) improves quality of life and prognosis in patients with coronary heart disease (CHD). The aim of the study was to evaluate effects of lipid-lowering therapy (LLT) in patients with CHD during and after CR. Methods: Data from prospective, multicenter registry including 1,100 patients with CHD undergoing CR in 6 German cardiac rehabilitation centers between 2016 and 2018 were analyzed. Results: The rate of statin-treated patients increased from 1,048 (96.3%) on admission to 1,062 (98.4%) at discharge ( Conclusions: During CR, LLT was effectively instituted and titrated, resulting in a high rate of statin-treated patients and a significant reduction in LDL-C. From this study, we hypothesize that CR is efficacious for adherence to LLT.

Indexed as

cardiac rehabilitationcoronary heart diseaselipid-lowering therapylipidsstatins

Identifiers

PMID40342982
PMCPMC12059688

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.